eMed
PrivateLast Round
Series A
Mar 26, 2026
Est. Valuation
$2B
Total Funding Raised
$200M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
eMed operates in Healthcare & Life Sciences and is based in Miami, Florida. Its latest recorded funding round was a Series A round in March 2026.
eMed is a healthtech company that provides a digital health platform offering telehealth services, at-home diagnostics, and clinically managed GLP-1 weight management programs for employers and individuals.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eMed Comparables
Compare eMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Everly Health | 83% | |
| LetsGetChecked | 80% | |
| Fuze Health | 74% |
For institutional investors. Book with your work email.
eMed Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
eMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Knighthead Capital Management | Series A |
| Paragon Biosciences | Series A |
| 8VC | Series A |
| Valor Equity Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 129% MoM, reaching 299.1K.
- Aug 1, 2026
Open roles increased to 158, 56% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 2, 2026
eMed Population Health, Inc. appoints Tom Finn as Executive Vice President, Sales, where he leads its enterprise sales organization and drives new-business sales strategy, execution, and revenue growth, in Florida on Nov 2nd '26.
- hiresNov 2, 2026
On Nov 2nd '26, eMed Population Health, Inc. appoints Tom Finn as Executive Vice President, Sales in Florida to lead its enterprise sales organization.
- hiresOct 19, 2026
eMed Population Health, Inc. appoints Marisstella Marinkovic as Chief Communications Officer on Oct 19th '26 in Florida; she leads strategic storytelling, executive communications, stakeholder engagement, and social media.
- partners_withSep 29, 2026
eMed Population Health, Inc. and The Female Quotient announced a strategic partnership to advance women’s health through discussions and activations, launching at the FQ Health Summit in New York on Oct 14th '26.
For institutional investors. Book with your work email.
eMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about eMed's valuation, stock price, and market status.
Is eMed a public or private company?
eMed is a private company.
What is the current stock price of eMed?
eMed is a private company, so its shares have no public market price. Caplight tracks eMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is eMed worth (valuation)?
eMed's valuation is estimated at $2.0B based on funding round data.
Can I buy eMed stock?
eMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was eMed's last funding round?
eMed's most recent funding round was Series A on March 26, 2026.
Who are the main investors in eMed?
Key investors in eMed include Knighthead Capital Management, Paragon Biosciences, 8VC, Valor Equity Partners.
Will eMed IPO soon?
No public IPO plans have been announced for eMed.
How can I track eMed secondary market activity?
Caplight tracks bids, offers, and trades in eMed's shares on secondary markets.